$102.89
-1.13[-1.09%]
At close: May 17
$102.89
0[0.00%]
After Hours: 4:04PM EDT
Crown Castle
(NYSE:CCI)Crown Castle Stock (NYSE:CCI), Analyst Ratings, Price Targets, Predictions
Crown Castle Inc has a consensus price target of $107.85, established from looking at the 97 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, Barclays, and Deutsche Bank on May 7, 2024, April 23, 2024, and April 22, 2024. With an average price target of $107 between RBC Capital, Barclays, and Deutsche Bank, there's an implied 3.99% upside for Crown Castle Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Barclays
Deutsche Bank
Wells Fargo
Argus Research
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Crown Castle
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | Buy Now | -2.81% | RBC Capital | Jonathan Atkin | $109 → $100 | Maintains | Sector Perform | Get Alert |
| 04/23/2024 | Buy Now | 8.85% | Barclays | Tim Long | $111 → $112 | Maintains | Equal-Weight | Get Alert |
| 04/22/2024 | Buy Now | 5.94% | Deutsche Bank | Matthew Niknam | $110 → $109 | Maintains | Hold | Get Alert |
| 04/19/2024 | Buy Now | -2.81% | Wells Fargo | Eric Luebchow | $115 → $100 | Maintains | Equal-Weight | Get Alert |
| 04/19/2024 | Buy Now | — | Argus Research | Marie Ferguson | — | Downgrade | Buy → Hold | Get Alert |
| 04/19/2024 | Buy Now | 2.05% | B of A Securities | David Barden | $120 → $105 | Maintains | Neutral | Get Alert |
| 04/18/2024 | Buy Now | 19.55% | Jefferies | Jonathan Petersen | $126 → $123 | Maintains | Buy | Get Alert |
| 04/18/2024 | Buy Now | 2.05% | BMO Capital | Ari Klein | $110 → $105 | Maintains | Market Perform | Get Alert |
| 04/18/2024 | Buy Now | 14.69% | Scotiabank | Maher Yaghi | $133 → $118 | Maintains | Sector Perform | Get Alert |
| 02/21/2024 | Buy Now | 5.94% | RBC Capital | Jonathan Atkin | $92 → $109 | Maintains | Sector Perform | Get Alert |
| 01/19/2024 | Buy Now | 6.91% | BMO Capital | Ari Klein | $107 → $110 | Upgrade | Underperform → Market Perform | Get Alert |
| 12/14/2023 | Buy Now | 6.91% | HSBC | Luigi Minerva | → $110 | Initiates | → Hold | Get Alert |
| 12/05/2023 | Buy Now | 11.77% | Wells Fargo | Eric Luebchow | $90 → $115 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/20/2023 | Buy Now | 18.57% | Citigroup | Michael Rollins | $126 → $122 | Maintains | Buy | Get Alert |
| 10/20/2023 | Buy Now | -12.53% | Wells Fargo | Eric Luebchow | $100 → $90 | Maintains | Underweight | Get Alert |
| 10/20/2023 | Buy Now | 1.08% | Raymond James | Ric Prentiss | $126 → $104 | Maintains | Outperform | Get Alert |
| 10/17/2023 | Buy Now | 22.46% | Citigroup | Michael Rollins | $138 → $126 | Maintains | Buy | Get Alert |
| 10/17/2023 | Buy Now | -2.81% | Wells Fargo | Eric Luebchow | $110 → $100 | Maintains | Underweight | Get Alert |
| 10/16/2023 | Buy Now | -2.81% | RBC Capital | Jonathan Atkin | $125 → $100 | Downgrade | Outperform → Sector Perform | Get Alert |
| 10/16/2023 | Buy Now | 9.83% | Morgan Stanley | Simon Flannery | $151 → $113 | Maintains | Overweight | Get Alert |
| 09/27/2023 | Buy Now | 8.85% | JP Morgan | Philip Cusick | $140 → $112 | Maintains | Neutral | Get Alert |
| 08/22/2023 | Buy Now | 22.46% | Raymond James | Ric Prentiss | $128 → $126 | Maintains | Outperform | Get Alert |
| 08/10/2023 | Buy Now | 11.77% | B of A Securities | David Barden | → $115 | Downgrade | Buy → Neutral | Get Alert |
| 08/02/2023 | Buy Now | 36.07% | Argus Research | Marie Ferguson | → $140 | Initiates | → Buy | Get Alert |
| 07/24/2023 | Buy Now | 21.49% | RBC Capital | Jonathan Atkin | $144 → $125 | Maintains | Outperform | Get Alert |
| 07/24/2023 | Buy Now | 12.74% | Barclays | Brendan Lynch | $137 → $116 | Maintains | Equal-Weight | Get Alert |
| 07/21/2023 | Buy Now | 24.4% | Raymond James | Ric Prentiss | $147 → $128 | Maintains | Outperform | Get Alert |
| 07/21/2023 | Buy Now | 6.91% | Wells Fargo | Eric Luebchow | $115 → $110 | Maintains | Underweight | Get Alert |
| 07/21/2023 | Buy Now | 3.02% | BMO Capital | Ari Klein | $113 → $106 | Maintains | Underperform | Get Alert |
| 07/20/2023 | Buy Now | 34.12% | Citigroup | Michael Rollins | $162 → $138 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Crown Castle (CCI)?
The latest price target for Crown Castle (NYSE: CCI) was reported by RBC Capital on May 7, 2024. The analyst firm set a price target for $100.00 expecting CCI to fall to within 12 months (a possible -2.81% downside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Crown Castle (CCI)?
The latest analyst rating for Crown Castle (NYSE: CCI) was provided by RBC Capital, and Crown Castle maintained their sector perform rating.
When was the last upgrade for Crown Castle (CCI)?
The last upgrade for Crown Castle Inc happened on January 19, 2024 when BMO Capital raised their price target to $110. BMO Capital previously had an underperform for Crown Castle Inc.
When was the last downgrade for Crown Castle (CCI)?
The last downgrade for Crown Castle Inc happened on April 19, 2024 when Argus Research changed their price target from N/A to N/A for Crown Castle Inc.
When is the next analyst rating going to be posted or updated for Crown Castle (CCI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crown Castle, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crown Castle was filed on May 7, 2024 so you should expect the next rating to be made available sometime around May 7, 2025.
Is the Analyst Rating Crown Castle (CCI) correct?
While ratings are subjective and will change, the latest Crown Castle (CCI) rating was a maintained with a price target of $109.00 to $100.00. The current price Crown Castle (CCI) is trading at is $102.89, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.